
领挚科技
领挚科技
Biotech/Healthcare
Lingzhi Technology integrates thin-film transistor semiconductor technology with life sciences to create a TFT biochip platform built around three core capabilities: microarray reaction control, picoliter-scale droplet manipulation, and in situ signal sensing. The platform has been commercialized…
Latest round: Pre Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.